These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 49382)

  • 1. Hyperlipidemia in coronary heart disease: a biochemical genetic approach.
    Goldstein JL; Brown MS
    J Lab Clin Med; 1975 Jan; 85(1):15-25. PubMed ID: 49382
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.
    Brown MS; Dana SE; Goldstein JL
    J Biol Chem; 1974 Feb; 249(3):789-96. PubMed ID: 4359767
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.
    Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):788-92. PubMed ID: 4362634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipid hypothesis. Genetic basis.
    Glueck CJ; Kwiterovich PO
    Arch Surg; 1978 Jan; 113(1):35-41. PubMed ID: 202221
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.
    Goldstein JL; Brown MS
    J Biol Chem; 1974 Aug; 249(16):5153-62. PubMed ID: 4368448
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial hypercholesterolemia. A genetic regulatory defect in cholesterol metabolism.
    Goldstein JL; Brown MS
    Am J Med; 1975 Feb; 58(2):147-50. PubMed ID: 163579
    [No Abstract]   [Full Text] [Related]  

  • 7. Homozygous familial hypercholesterolemia: specificity of the biochemical defect in cultured cells and feasibility of prenatal detection.
    Goldstein JL; Harrod MJ; Brown MS
    Am J Hum Genet; 1974 Mar; 26(2):199-206. PubMed ID: 4362800
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of the familial hypercholesterolemia gene in heterozygotes: model for a dominant disorder in man.
    Goldstein JL; Brown MS
    Trans Assoc Am Physicians; 1974; 87():120-31. PubMed ID: 4376290
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man.
    Brown MS; Goldstein JL
    Science; 1974 Jul; 185(4145):61-3. PubMed ID: 4366052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol.
    Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2804-8. PubMed ID: 4355366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypercholesterolemia: genetic, biochemical and pathophysiologic considerations.
    Brown MS; Goldstein JL
    Adv Intern Med; 1975; 20():273-96. PubMed ID: 1090121
    [No Abstract]   [Full Text] [Related]  

  • 12. Turnover of cholesteryl esters in plasma low-density and high-density lipoproteins in familial hyperbetalipoproteinaemia.
    Myant NB; Balasubramaniam S; Moutafis CD; Mancini M; Slack J
    Clin Sci Mol Med; 1973 Oct; 45(4):551-60. PubMed ID: 4356485
    [No Abstract]   [Full Text] [Related]  

  • 13. Human mutations affecting the low density lipoprotein pathway.
    Brown MS; Goldstein JL
    Am J Clin Nutr; 1977 Jun; 30(6):975-8. PubMed ID: 194472
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholesterol synthesis by cultured fibroblasts: decreased feedback inhibition in familial hypercholesterolemia.
    Khachadurian AK; Kawahara FS
    J Lab Clin Med; 1974 Jan; 83(1):7-15. PubMed ID: 4855550
    [No Abstract]   [Full Text] [Related]  

  • 15. [Regulation of low (LDL) and high (HDL) density lipoprotein binding sites on fibroblasts of metabolically healthy and homozygote familial hypercholesteremic (HFH) subjects].
    Koschinsky T; Carew TE; Steinberg D
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():378-81. PubMed ID: 206052
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.
    Goldstein JL; Dana SE; Brunschede GY; Brown MS
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):1092-6. PubMed ID: 236556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous hypercholesteraemia and the portacaval shunt. The need for a concerted attack by surgeons and clinical researchers.
    Ahrens EH
    Lancet; 1974 Aug; 2(7878):449-51. PubMed ID: 4136785
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipoprotein receptors, cholesterol metabolism, and atherosclerosis.
    Goldstein JL; Brown MS
    Arch Pathol; 1975 Apr; 99(4):181-4. PubMed ID: 163632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypercholesterolemia: A genetic defect in the low-density lipoprotein receptor.
    Brown MS; Goldstein JL
    N Engl J Med; 1976 Jun; 294(25):1386-90. PubMed ID: 177875
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol synthesis and uptake by fat cells in familial hypercholesterolemia.
    Kovanen PT; Nikkilä EA
    Adv Exp Med Biol; 1977; 82():286-9. PubMed ID: 200097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.